Emily Hill
2019
In 2019, Emily Hill earned a total compensation of $2.3M as Chief Financial Officer at PTC Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $228,250 |
|---|---|
| Option Awards | $1,609,140 |
| Salary | $367,530 |
| Stock Awards | $120,061 |
| Other | $11,667 |
| Total | $2,336,648 |
Hill received $1.6M in option awards, accounting for 69% of the total pay in 2019.
Hill also received $228.3K in non-equity incentive plan, $367.5K in salary, $120.1K in stock awards and $11.7K in other compensation.
Rankings
In 2019, Emily Hill's compensation ranked 5,161st out of 13,971 executives tracked by ExecPay. In other words, Hill earned more than 63.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,161 out of 13,971 | 63rd |
Division Manufacturing | 1,915 out of 5,701 | 66th |
Major group Chemicals And Allied Products | 674 out of 2,200 | 69th |
Industry group Drugs | 565 out of 1,886 | 70th |
Industry Pharmaceutical Preparations | 422 out of 1,398 | 70th |
Source: SEC filing on April 29, 2021.
Hill's colleagues
We found four more compensation records of executives who worked with Emily Hill at PTC Therapeutics in 2019.